Register entry

AbbVie Deutschland GmbH & Co Kg

Data as of · How to read this entry

Registered sites
0
Active NDC listings
11
Live patents
0
Countries
0
Catalogue

Drug listings by form and route

11

11 active NDC listings: 11 drug for further processing. By marketing category: DRUG FOR FURTHER PROCESSING 11.

Dosage formNDCs
tablet, film coated7
pellet2
tablet2
RouteNDCs
Labeller name on the listingNDCs
abbvie deutschland gmbh & co kg11
Catalogue

Marketed products

11
BrandGeneric nameForm / routeNDC
-Glecaprevirpellet12613-3048DRUG FOR FURTHER PROCESSING
-Glecaprevir CV Pibrentasvirtablet, film coated12613-2625DRUG FOR FURTHER PROCESSING
-Lopinavir and Ritonavirtablet, film coated12613-0522DRUG FOR FURTHER PROCESSING
-Lopinavir and Ritonavirtablet12613-1575DRUG FOR FURTHER PROCESSING
-Lopinavir and Ritonavirtablet12613-2605DRUG FOR FURTHER PROCESSING
-Lopinavir and Ritonavirtablet, film coated12613-3008DRUG FOR FURTHER PROCESSING
-Lopinavir and Ritonavirtablet, film coated12613-4014DRUG FOR FURTHER PROCESSING
-Lopinavir and Ritonavirtablet, film coated12613-6799DRUG FOR FURTHER PROCESSING
-Pibrentasvirpellet12613-3049DRUG FOR FURTHER PROCESSING
-Ritonavirtablet, film coated12613-2340DRUG FOR FURTHER PROCESSING
-Ritonavirtablet, film coated12613-3333DRUG FOR FURTHER PROCESSING
Compare

Other companies listing lopinavir and ritonavir

Enquiry

Common questions

Is AbbVie Deutschland GmbH & Co Kg FDA approved?
AbbVie Deutschland GmbH & Co Kg holds no registered establishment of its own; 11 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does AbbVie Deutschland GmbH & Co Kg make?
11 products are listed under AbbVie Deutschland GmbH & Co Kg in the openFDA NDC Directory, most often as tablet, film coated; pellet; tablet. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.